Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:GBNH

Greenbrook TMS (GBNH) Stock Price, News & Analysis

Greenbrook TMS logo

About Greenbrook TMS Stock (NASDAQ:GBNH)

Advanced Chart

Key Stats

Today's Range
$0.04
$0.10
50-Day Range
$0.05
$0.38
52-Week Range
$0.10
$1.82
Volume
787,000 shs
Average Volume
3.60 million shs
Market Capitalization
$1.96 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Greenbrook TMS Inc., together with its subsidiaries, controls and operates a network of outpatient mental health services centers in the United States. Its centers specialize in the provision of transcranial magnetic stimulation (TMS) therapy, an FDA-cleared non-invasive therapy for the treatment of major depressive disorder and other mental health disorders, as well as related psychiatric services. As of December 31, 2021, the company operated 94 wholly owned and 55 TMS centers in the commonwealth of Virginia and the States of Maryland, Delaware, North Carolina, Missouri, Illinois, Ohio, Texas, Connecticut, Florida, South Carolina, Michigan, Alaska, Oregon, California, Iowa, and Massachusetts. Greenbrook TMS Inc. was founded in 2011 and is headquartered in Toronto, Canada.

Receive GBNH Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Greenbrook TMS and its competitors with MarketBeat's FREE daily newsletter.

GBNH Stock News Headlines

Neuronetics reports preliminary Q4 revenue $22.1M, consensus $18.98M
Neuronetics Provides Business Update and Issues 2025 Guidance
Think NVDA’s run was epic? You ain’t seen nothin’ yet
Ask most investors and they’ll probably tell you Nvidia is the undisputed AI stock of the decade. In 2023, it surged 239%. And in 2024, it soared another 171% on the year… But what if I told you there was a way to target those types of “peak Nvidia” profit opportunities in 24 hours or less?
Greenbrook TMS Inc (GBNHF)
Greenbrook TMS Strategic Acquisition and Restructuring by Neuronetics
Neuronetics Sees Q3 Revenue Rise Amid Strategic Acquisition
Neuronetics stockholders approve acquisition of Greenbrook TMS
Greenbrook TMS Shareholders Approve Neuronetics Acquisition
See More Headlines

GBNH Stock Analysis - Frequently Asked Questions

Greenbrook TMS Inc. (NASDAQ:GBNH) released its quarterly earnings data on Monday, August, 14th. The company reported ($0.30) EPS for the quarter, missing the consensus estimate of ($0.29) by $0.01. The company earned $18.35 million during the quarter, compared to the consensus estimate of $19.15 million.

Based on aggregate information from My MarketBeat watchlists, some other companies that Greenbrook TMS investors own include RENN Fund (RCG), Aceragen (ACGN), Alimera Sciences (ALIM), Alpine Summit Energy Partners (ALPS), Angion Biomedica (ANGN), AirNet Technology (ANTE) and Aptorum Group (APM).

Company Calendar

Last Earnings
8/14/2023
Today
5/17/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Miscellaneous health & allied services, not elsewhere classified
Sub-Industry
N/A
Current Symbol
NASDAQ:GBNH
Fax
N/A
Employees
492
Year Founded
N/A

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-61,730,000.00
Pretax Margin
-83.55%

Debt

Sales & Book Value

Annual Sales
$69.10 million
Price / Cash Flow
N/A
Book Value
($1.72) per share
Price / Book
-0.03

Miscellaneous

Free Float
31,959,000
Market Cap
$1.96 million
Optionable
Not Optionable
Beta
2.19
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (NASDAQ:GBNH) was last updated on 5/18/2025 by MarketBeat.com Staff
From Our Partners